Promising results from phase III trials of alemtuzumab, taken once-yearly by infusion, and oral BG-12 were reported in April at the annual American Academy of Neurology meeting.
Promising results from phase III trials of alemtuzumab (Genzyme/Sanofi), taken once-yearly by infusion, and oral BG-12 (Biogen Idec) were reported in April at the annual American Academy of Neurology meeting in New Orleans. Genzyme says they’ll file soon for FDA approval of alemtuzumab; Biogen has already submitted BG-12 for FDA approval.
On May 23, from 7:00-8:00 p.m. ET, join a panel of experts for a live nationwide webcast “The Next Frontier: Understanding and Treating Progressive MS.” Topics will include: Why there aren’t more treatments for progressive MS; what’s on the horizon for stopping or reversing progression; and things people can do to maximize their quality of life.
Thanks to the generosity of Pure Protein, your gift will be doubled to help us get that much closer to a world free of MS by funding research and supporting programs and services that touch the lives of people with MS and their families.
May 11: Speeding clinical trials for people with progressive MS: Outcomes published from an international workshop on MS disability measurement tools
April 25: What triggers MS in kids? Pediatric network and other sites recruiting for study of environmental and genetic risk factors
This communication is partially sponsored through the generous support of
Biogen Idec; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS. JOIN THE MOVEMENT®
Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please visit our website.
Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.
National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017
This message was sent to .
To ensure that you continue to receive our emails, please add us to your address book.
Join Us
Facebook Twitter LinkedIn YouTube Pinterest MS Connection